Precision Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Precision Oncology
Jul 25, 2024, 00:36 |
Blog
Diana Romero: AI, exploiting bacteria, multiple myeloma and more in the new issue of Nature Reviews Clinical Oncology
Diana Romero, Chief Editor at Nature Research, shared on LinkedIn: "A new issue of Nature…
Jul 24, 2024, 02:14 |
Blog
Jing Ping Yeo: Establishment of the Asia Pacific Oncology Drug Development Consortium
Jing Ping Yeo, Head of transformation, Operational Enablers, Commercial Excellence, Accelerate Growth at George Clinical,…
Jul 22, 2024, 14:55 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Douglas Flora
We are happy to feature Dr. Douglas Flora, as our next oncoinfluencer. Dr. Flora is…
Jul 19, 2024, 06:05 |
Insight
How Genomate is paving the way for more precise, effective lung cancer treatments
Genomate Health shared a post on LinkedIn about a recent paper by Anna Dirner et…
Jul 15, 2024, 02:10 |
Blog
Mammary Cell News congratulates Drs. Carlos Ronchi, Cathrin Brisken on recent NPJ Journals study
Cathrin Brisken, Professor at The Institute of Cancer Research, shared a post by Mammary Cell…
Jul 14, 2024, 13:22 |
Blog
Opportunities to improve outcomes by measuring the quality of precision oncology - Marathon of Hope Cancer Centres Network
Yvonne Bombard, Canada Research Chair at Unity Health Toronto, shared a post by Marathon of…
Jul 14, 2024, 06:14 |
Insight
Matching Patients with Treatments featuring Istvan Petak
Genomate Health shared on LinkedIn: "We all know someone whose life has been touched by…
Jul 13, 2024, 04:51 |
Dialogues
ASCO24 Updates: Pancreas-View: AI-Powered Precision Medicine for Pancreatic Cancer Treatment
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 12, 2024, 17:13 |
Blog
Melvin LK Chua: Join the meeting that covers the breath of Cancer Science
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Jul 1, 2024, 16:19 |
Insight
Vivek Subbiah: Two back to back futuristic papers in the journal AI In Precision Oncology
Vivek Subbiah shared on LinkedIn: “Thrilled to have the opportunity to mentor some of the…
Jul 1, 2024, 15:00 |
Blog
Razelle Kurzrock: Universal germline and somatic genomic testing is the key for cancer!
Razelle Kurzrock, Chair of Precision Oncology at MCW Cancer Center, shared a post on X:…
Jun 28, 2024, 15:12 |
Blog
Wafik S. El-Deiry: Excellent opportunities for collaboration in developing novel therapeutic trials and precision oncology efforts
Wafik S. El-Deiry shared on LinkedIn: . “Great to spend time with Dr.…
Jun 28, 2024, 15:06 |
Blog
Sarah Cohen-Gogo: Join KiCS program oncology team
Sarah Cohen-Gogo, Pediatric Oncologist and Transition Clinician-Scientist at The Hospital for Sick Children, shared a…
Jun 28, 2024, 05:37 |
Blog
Istvan Petak: Pleasure to give a talk at the Drug Development Course 2024
Istvan Petak shared on LinkedIn: “Hello, amazing Switzerland, beautiful Bellinzona. It was a pleasure to…
Jun 27, 2024, 03:46 |
Blog
Submit your abstract for the Molecular Analysis for Precision Oncology Congress 2024 in London - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “Submit your abstract for the…
Jun 25, 2024, 03:26 |
Blog
Vivek Subbiah: Such a delight to have our paper published in a journal with the highest impact factor
Vivek Subbiah shared on LinkedIn: "2023 Impact factors for all journals are out!!! CA: A Cancer…
Jun 22, 2024, 01:35 |
Blog
Douglas Flora: Our shared mission of AI, to fight cancer, drives us forward every day
Douglas Flora recently shared a post on LinkedIn: "Our shared mission—to harness the power of…
Jun 20, 2024, 16:35 |
Insight
Key takeaways on precision oncology in pediatric and AYA sarcomas by Dr. Jack Shern
Shushan Hovsepyan shared on LinkedIn: "Yesterday I was watching a super informative lecture from the American…
Jun 17, 2024, 15:06 |
Dialogues
Oncodaily Dialogues #9 István Peták/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Jun 14, 2024, 13:17 |
Blog
We are still catching our breath from ASCO24 - Realyze Intelligence
Realyze Intelligence shared on LinkedIn: " What. An. ASCO24. It's been a week and we…
Jun 14, 2024, 03:24 |
Blog
Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X: “PI3K/Akt-targeted agents entered…
Jun 14, 2024, 00:54 |
Insight
Lisa Kaufman: BioVoice discusses Parexel's new "Advancing Precision Oncology" report
Lisa Kaufman, Senior Manager at Paraxel Meeting Services, shared a post on X: "While advancements…
Jun 11, 2024, 12:19 |
Career
Jane B. is starting a new position as Medical Affairs Lead, Precision Oncology at AstraZeneca!
Jane B., Medical Affairs Lead, Precision Oncology at AstraZeneca, shared on LinkedIn: “I’m happy to…
Jun 10, 2024, 05:09 |
Insight
Saurabh Zanwar: Impact of Extramedullary Multiple Myeloma on Outcomes with Ide-cel
Saurabh Zanwar, Assistant Professor at Mayo Clinic, shared on X: “Out now in Journal of…
Jun 8, 2024, 11:24 |
Blog
Kristiyana Kaneva: Packed several days at ASCO with Tempus AI
Kristiyana Kaneva, Executive Medical Director, Clinical Development at Tempus AI, shared a post on LinkedIn:…
Jun 3, 2024, 22:51 |
Insight
Vivek Subbiah: The evolving landscape of tissue-agnostic therapies in precision oncology
Vivek Subbiah recently shared the following insight on LinkedIn: "HOT OFF THE PRESS Just in…
Jun 2, 2024, 11:16 |
Insight
Giannis Mountzios: Lorlatinib in ALK positive NSCLC sets a new benchmark in Precision Oncology
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
May 30, 2024, 02:01 |
Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 27, 2024, 04:49 |
Insight
Ben Westphalen: Revolutionary way of creating access to molecularly guided treatment options
Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared on…
May 26, 2024, 08:03 |
Insight
Erick Saldanha: The role of liquid biopsy in the sustained progression of precision oncology
Erick Saldanha, Medical Oncologist and Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, recently shared…
May 26, 2024, 05:44 |
Insight
Mutlu Demiray: Discover how vMTBs are shaping the future of cancer care
Mutlu Demiray, Chief Physician in the Department of Oncology at Medicana International Hospital, shared a…
May 25, 2024, 10:34 |
Insight
Jacob Adashek: Excited to be with such a great group of ASCO Featured Voices
Jacob Adashek, Medical oncology fellow at the Sidney Kimmel Comprehensive Cancer Center at the Johns…
May 19, 2024, 15:15 |
Insight
Vivek Subbiah: Precision Oncology NTRK - How to you pick needles from the haystack?
Vivek Subbiah shared on LinkedIn: "Pleased to share our editorial American Cancer Society Journal Cancer. TRKing…
May 18, 2024, 02:54 |
Societies
Abstract submission for the Molecular Analysis for Precision Oncology Congress 2024 is now open - ESMO
ESMO shared on X: "MAP2024: Abstract submission for the Molecular Analysis for Precision Oncology Congress…
May 16, 2024, 14:13 |
Opinion
Paolo Tarantino: A tremendous opportunity to validate the potential of HER2DX to predict outcomes in HER2+ BC
Paolo Tarantino made the following post on X: “HER2DX to Be Validated in Pivotal ECOG-ACRIN CompassHER2…
May 16, 2024, 11:47 |
Insight
Aakash Desai: We explored the molecular characteristics of KRAS wildtype PDAC
Aakash Desai, Assistant Professor at O'Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: "In…
May 13, 2024, 08:24 |
Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 12, 2024, 12:19 |
Blog
Kevin Bambury: The latest version of our Frailty Assessment tool!
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University, shared a post by Kevin Bambury,…
May 2, 2024, 23:45 |
Insight
Aakash Desai: Insights into mNSCLC Management through a Global Clinician Survey
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared a post on…
May 2, 2024, 14:25 |
Insight
Fabrice Andre: A nice seminar around Precision Medicine
Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…
May 2, 2024, 02:08 |
Blog
Variant allele frequency by Vivek Subbiah
Vivek Subbiah shared on X: "Variant allele frequency: a decision-making tool in precision oncology? Trends…
May 1, 2024, 20:07 |
Blog
Vivek Subbiah: Looking forward to delivering the keynote at the esteemed PRISM center in Paris
Vivek Subbiah shared a post on LinkedIn: “Just landed in Paris! Looking forward to delivering…
Apr 29, 2024, 14:03 |
Blog
Jeanne Kowalski: Our latest innovation featured on the cover of AI in Precision Oncology
Douglas Flora shared a post by Jeanne Kowalski, Professor and Associate Director of Cancer Clinical Genomics…
Apr 27, 2024, 11:47 |
Blog
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini and Semir Vranić - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on LinkedIn: “Dive deep into the world of lung…
Apr 23, 2024, 12:12 |
Societies
Vivek Subbiah: Fantastic overview of Molecular Tumor Boards - MTB 101 and in-depth thought-provoking lecture by the amazing Ben Westphalen
Vivek Subbiah shared a post on X: "Fantastic overview of Molecular Tumor Boards - MTB…
Apr 23, 2024, 11:34 |
Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 22, 2024, 14:45 |
Blog
Sylvester Comprehensive Cancer Center - the 2nd Biennial Miami Precision Medicine Conference focused on unraveling the DNA code
An event by Sylvester Comprehensive Cancer Center on May 4-5, sponsored by the University of…
Apr 19, 2024, 20:37 |
Societies
Vivek Subbiah: 4th ESMO webinar of the Precision Oncology series
Vivek Subbiah shared a post by Diogo Martins Branco, Board Member at AICSO, on X/Twitter,…
Apr 17, 2024, 12:19 |
Blog
Angela Mastronuzzi: Special Collection on 'Pediatric Precision Oncology: Target Therapy/New Drugs in Pediatric Brain Tumors'
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, shared a post on…
Apr 14, 2024, 13:10 |
Blog
Herbert Loong: Had opportunity to welcome colleagues from Bayer AG Company
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post…
Apr 11, 2024, 16:08 |
Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 7, 2024, 23:34 |
Blog
Manmeet Ahluwalia: Look forward to host the Second Miami Cancer Institute Precision Oncology Symposium
Manmeet Ahluwalia, Chief of Medical Oncology at Miami Cancer Institute, shared on LinkedIn: “Look forward…
Apr 7, 2024, 12:23 |
Blog
Karan Cushman: How can clinicians leverage all that AI offers and thoughtfully apply it in oncology care?
Karan Cushman, Chief Vision Officer at Cushman Creative, shared on Linkedin: "Episode #59: How can clinicians…
Apr 4, 2024, 01:44 |
Opinion
Douglas Flora: The production of our second issue of AI in Precision Oncology is well underway and promises to deliver an array of significant papers very soon
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on…
Apr 2, 2024, 12:50 |
Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Mar 22, 2024, 05:19 |
Blog
Erika Hamilton: 100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials
Erika Hamilton and Vivek Subbiah shared a post by Sarah Cannon Research Institute: "Several years ago,…
Mar 16, 2024, 10:45 |
Drugs
Vivek Subbiah: Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer
Vivek Subbiah recently shared a post on X/Twitter: “Exceptional Responses to Selpercatinib in RET Fusion–Driven…
Mar 8, 2024, 19:56 |
Insight
Vivek Subbiah: How can we Modernize Precision Oncology With Decentralized Trial Tools?
Vivek Subbiah recently shared on LinkedIn: "Precision oncology has seen exciting developments in recent years with…
Mar 6, 2024, 09:42 |
Blog
Wafik El-Deiry: The founders of the WIN Consortium had a bold vision for global impact in personalized cancer medicine
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Mar 5, 2024, 13:37 |
Blog
Wafik El-Deiry: I heard there are over 450 people registered for the 2024 WIN Symposium
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Mar 2, 2024, 23:07 |
Blog
Vivek Subbiah: Such an honor to be invited to the WIN symposium, Abu Dhabi, UAE
Vivek Subbiah recently shared on X: “Announcement: Tumor-Agnostic Precision Oncology goes global Such an honor…
Mar 1, 2024, 18:40 |
Blog
Sendurai Mani: My good friend John Tarantino delivered a remarkable TEDX talk on Redemption in 2023
Sendurai Mani, Dean’s Chair of Translational Oncology at Brown University, shared a post on LinkedIn:…
Feb 29, 2024, 05:20 |
Blog
Wafik S. El-Deiry: Very much looking forward to traveling and attending the 2024 WIN Consortium in Cancer Personalized Medicine Symposium in Abu Dhabi
Wafik S. El-Deiry shared on LinkedIn: "Very much looking forward to traveling and attending the…
Feb 17, 2024, 17:47 |
Insight
Vivek Subbiah: Delighted to share Modernize Precision Oncology With Decentralized Trial Tools
Vivek Subbiah shared a post on X: "Hot off the press JAMA Oncology: Delighted to…
Feb 13, 2024, 18:59 |
Blog
Douglas Flora: We are launching AI in Precision Oncology this week
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, recently posted on…
Feb 13, 2024, 01:50 |
Blog
Vivek Subbiah: Pleased to share our editorial in on Direct-to-Patient Clinical Trials
Vivek Subbiah shared a post on LinkedIn: "Pleased to share our editorial in American Association…
Feb 9, 2024, 15:06 |
Opinion
Corrie Painter: Precision oncology is sometimes about airplanes and babysitters
Corrie Painter, Strategic Advisor at Broad Institute of MIT and Harvard, recently posted on LinkedIn:…
Feb 9, 2024, 14:38 |
Blog
Douglas Flora: Another example of a practical and impactful benefit of AI and pattern recognition
Douglas Flora, Executive Medical Director, Oncology Services at St. Elizabeth Healthcare, recently posted on LinkedIn:…
Jan 31, 2024, 17:56 |
Insight
Istvan Petak: Only computational solutions can overcome the challenge of genomic complexity
Istvan Petak, Adjunct Professor at University of Illinois Chicago, shared on LinkedIn: "Hello, Bangalore, India.…
Jan 25, 2024, 15:53 |
Blog
New peer-reviewed journal ESMO Gastrointestinal Oncology
Quoting ESMO - European Society for Medical Oncology on LinkedIn: "ESMO Daily Reporter: Over the…
Jan 12, 2024, 22:39 |
Blog
Vivek Subbiah: Optimizing anti–body drug conjugates and radiopharmaceuticals for precision therapy
Vivek Subbiah shared a post on LinkedIn: “Sharing this editorial from 2021: Optimizing anti–body drug conjugates…
Dec 27, 2023, 17:02 |
Blog
Vivek Subbiah: Forward-thinking journal on AI in Oncology and precision medicine
Vivek Subbiah shared on X/Twitter: Just in time for the holidays. Nice to get the…
Dec 24, 2023, 18:34 |
Insight
Norbert Kraut: A must-read Precision Oncology: 2023 in Review
Norbert Kraut, Global Head of Cancer Research, Boehringer Ingelheim, shared on X/Twitter: "2023 has been…
Dec 20, 2023, 11:33 |
Blog
Douglas Flora: Nikhil is the kind of leader who challenges conventional healthcare paradigms
Douglas Flora, Executive Medical Director, Oncology Services at St. Elizabeth Healthcare, shared a post by…
Dec 15, 2023, 15:46 |
Blog
Douglas Flora: How AI will play a prominent role in that future
Douglas Flora, Executive Medical Director for Oncology Services at St. Elizabeth Healthcare, shared on LinkedIn:…
Dec 12, 2023, 17:51 |
Insight
Paola Ghanem: Our work on the druggable genomic landscape of GBM is finally out
Paola Ghanem, Resident at the Osler Medical Residency at the Johns Hopkins Hospital, shared on…
Nov 11, 2023, 12:49 |
Blog
Benedikt Westphalen: CUPISCO is out in ESMO Open
Benedikt Westphalen, Medical Lead of Precision Oncology at the Cancer Center Munich, shared on LinkedIn:…
Oct 28, 2023, 03:09 |
Insight
Sandra Algarín-Perneth: The success of precision oncology guided by HER2 genomic profiling - a rare neuroendocrine carcinoma case
Sandra Algarín-Perneth, Postdoctoral Research Fellow in Gastroenterology and Hepatology at Mayo Clinic, shared on Twitter:…
Oct 18, 2023, 16:54 |
Blog
Join us for an upcoming webinar on Precision Oncology on November 13, 2023 - The Multinational Association of Supportive Care in Cancer (MASCC)
The Multinational Association of Supportive Care in Cancer (MASCC) shared on LinkedIn: "Join us for…
Sep 17, 2023, 18:35 |
Drugs
,
Insight
Drew Moghanaki: Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC.
Drew Moghanaki, Co-Chair of VA Lung Precision Oncology Program Biomarker Subworkgroup at U.S. Department of…
Sep 16, 2023, 19:08 |
Insight
Vivek Subbiah: Super thrilled to deliver the keynote lecture on “Precision Oncology: Future is now” at the Binaytara Foundation.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, recently shared…
Sep 12, 2023, 19:00 |
Insight
Douglas Flora: Exciting updates from “AI in Precision Oncology”, the first ever peer-reviewed journal dedicated to this important topic.
Douglas Flora, the Executive Medical Director of Oncology Services in St. Elizabeth Healthcare, recently shared…
Sep 5, 2023, 17:18 |
Insight
Vivek Subbiah: Give the right drug, to the right patient, at the right time in every country, to think globally and act locally.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on LinkedIn:…
Aug 13, 2023, 18:49 |
Insight
Hinco J. Gierman: It underscores the importance of rapid testing and getting patients on the right treatment.
As stated by Hinco J. Gierman, Vice President of Precision Oncology, on LinkedIn: "We published…
All:
84
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube